Decreased circulating klotho levels in patients undergoing dialysis and relationship to oxidative stress and inflammation

Peritoneal Dialysis International

Volumn 35, Issue 1, 2015, Pages 43-51

  Oh, Hyung Jung ^a   Nam, Bo Young ^b   Lee, Mi Jung ^a   Kim, Chan Ho ^a   Koo, Hyang Mo ^a   Doh, Fa Mee ^a   Han, Jae Hyun ^a   Kim, Eun Jin ^a   Han, Ji Suk ^a   Park, Jung Tak ^a   Yoo, Tae Hyun ^a   Kang, Shin Wook ^a,b   Han, Dae Suk ^a   Han, Seung Hyeok ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

ESRD; Inflammation; Klotho; Oxidative stress

Indexed keywords

8 ISOPROSTANE; C REACTIVE PROTEIN; CALCIUM; CREATININE; GLUCOSE; INTERLEUKIN 6; KLOTHO PROTEIN; PARATHYROID HORMONE; PHOSPHORUS; UREA; 8-EPI-PROSTAGLANDIN F2ALPHA; BETA GLUCURONIDASE; BIOLOGICAL MARKER; PROSTAGLANDIN F2 ALPHA;

ADULT; AGE; ARTICLE; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; END STAGE RENAL DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL KIDNEY DISEASE; FEMALE; HUMAN; HYPERTENSION; INFLAMMATION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; OXIDATIVE STRESS; PERITONEAL DIALYSIS; PRIORITY JOURNAL; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; BLOOD; COMPARATIVE STUDY; FOLLOW UP; KIDNEY FAILURE, CHRONIC; METABOLISM; MORTALITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME;

BIOMARKERS; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DINOPROST; FEMALE; FOLLOW-UP STUDIES; GLUCURONIDASE; HUMANS; INFLAMMATION; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; MALE; OXIDATIVE STRESS; PERITONEAL DIALYSIS; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84928476747     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2013.00150     Document Type: Article

References (40)

1. Port FK. Morbidity and mortality in dialysis patients. Kidney Int 1994; 46:1728–37.
2. Patient mortality and survival. United states renal data system. Am J Kidney Dis 1998; 32:S69–80.
3. K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 2005; 45:S1–153.
4. Baigent C, Burbury K, Wheeler D. Premature cardiovascular disease in chronic renal failure. Lancet 2000; 356:147–52.
5. Goicoechea M, de Vinuesa SG, Gomez-Campdera F, Luno J. Predictive cardiovascular risk factors in patients with chronic kidney disease (CKD). Kidney Int Suppl 2005:S35–8.
6. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM. The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 2002; 62:1524–38.
7. Sundl I, Roob JM, Meinitzer A, Tiran B, Khoschsorur G, Haditsch B, et al. Antioxidant status of patients on peritoneal dialysis: Associations with inflammation and glycoxidative stress. Perit Dial Int 2009; 29:89–101.
8. Guo CH, Wang CL, Chen PC, Yang TC. Linkage of some trace elements, peripheral blood lymphocytes, inflammation, and oxidative stress in patients undergoing either hemodialysis or peritoneal dialysis. Perit Dial Int 2011; 31:583–91.
9. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 1997; 390:45–51.
10. Mitani H, Ishizaka N, Aizawa T, Ohno M, Usui S, Suzuki T, et al. In vivo klotho gene transfer ameliorates angiotensin ii-induced renal damage. Hypertension 2002; 39:838–43.
11. Aizawa H, Saito Y, Nakamura T, Inoue M, Imanari T, Ohyama Y, et al. Downregulation of the klotho gene in the kidney under sustained circulatory stress in rats. Biochem Biophys Res Commun 1998; 249:865–71.
12. Zhao Y, Banerjee S, Dey N, LeJeune WS, Sarkar PS, Brobey R, et al. Klotho depletion contributes to increased inflammation in kidney of the db/db mouse model of diabetes via RelA (serine)536 phosphorylation. Diabetes 2011; 60:1907–16.
13. Asai O, Nakatani K, Tanaka T, Sakan H, Imura A, Yoshimoto S, et al. Decreased renal alpha-klotho expression in early diabetic nephropathy in humans and mice and its possible role in urinary calcium excretion. Kidney Int 2012; 81:539–47.
14. Sugiura H, Yoshida T, Tsuchiya K, Mitobe M, Nishimura S, Shirota S, et al. Klotho reduces apoptosis in experimental ischaemic acute renal failure. Nephrol Dial Transplant 2005; 20:2636–45.
15. Koh N, Fujimori T, Nishiguchi S, Tamori A, Shiomi S, Nakatani T, et al. Severely reduced production of klotho in human chronic renal failure kidney. Biochem Biophys Res Commun 2001; 280:1015–20.
16. Kim HR, Nam BY, Kim DW, Kang MW, Han JH, Lee MJ, et al. Circulating alpha-klotho levels in CKD and relationship to progression. Am J Kidney Dis 2013.
17. Kurosu H, Ogawa Y, Miyoshi M, Yamamoto M, Nandi A, Rosenblatt KP, et al. Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem 2006; 281:6120–3.
18. Kuro-o M. Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism. Curr Opin Nephrol Hypertens 2006; 15:437–41.
19. Kurosu H, Yamamoto M, Clark JD, Pastor JV, Nandi A, Gurnani P, et al. Suppression of aging in mice by the hormone klotho. Science 2005; 309:1829–33.
20. Yamamoto M, Clark JD, Pastor JV, Gurnani P, Nandi A, Kurosu H, et al. Regulation of oxidative stress by the anti-aging hormone klotho. J Biol Chem 2005; 280:38029–34.
21. Liu F, Wu S, Ren H, Gu J. Klotho suppresses RIG-I-mediated senescence-associated inflammation. Nat Cell Biol 2011; 13:254–62.
22. Yamazaki Y, Imura A, Urakawa I, Shimada T, Murakami J, Aono Y, et al. Establishment of sandwich ELISA for soluble alpha-klotho measurement: Age-dependent change of soluble alpha-klotho levels in healthy subjects. Biochem Biophys Res Commun 2010; 398:513–8.
23. Watson PE, Watson ID, Batt RD. Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 1980; 33:27–39.
24. Wang Y, Sun Z. Current understanding of klotho. Ageing Res Rev 2009; 8:43–51.
25. Kuro-o M. Klotho as a regulator of oxidative stress and senescence. Biol Chem 2008; 389:233–41.
26. Cachofeiro V, Goicochea M, de Vinuesa SG, Oubina P, Lahera V, Luno J. Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. Kidney Int Suppl 2008:S4–9.
27. Himmelfarb J, Hakim RM. Oxidative stress in uremia. Curr Opin Nephrol Hypertens 2003; 12:593–8.
28. Vaziri ND. Oxidative stress in uremia: Nature, mechanisms, and potential consequences. Semin Nephrol 2004; 24:469–73.
29. Lim PS, Chang YM, Thien LM, Wang NP, Yang CC, Chen TT, et al. 8-iso-prostaglandin F2alpha as a useful clinical biomarker of oxidative stress in ESRD patients. Blood Purif 2002; 20:537–42.
30. Sakamoto H, Corcoran TB, Laffey JG, Shorten GD. Isoprostanes—markers of ischaemia reperfusion injury. Eur J Anaesthesiol 2002; 19:550–9.
31. Izquierdo MC, Perez-Gomez MV, Sanchez-Nino MD, Sanz AB, Ruiz-Andres O, Poveda J, et al. Klotho, phosphate and inflammation/ageing in chronic kidney disease. Nephrol Dial Transplant 2012; 27(Suppl 4):46–10.
32. Nguyen-Khoa T, Massy ZA, De Bandt JP, Kebede M, Salama L, Lambrey G, et al. Oxidative stress and haemodialysis: Role of inflammation and duration of dialysis treatment. Nephrol Dial Transplant 2001; 16:335–40.
33. Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease. Kidney Int 2007; 71:31–8.
34. Kim HR, Nam BY, Kim DW, Kang MW, Han JH, Lee MJ, et al. Circulating alpha-klotho levels in CKD and relationship to progression. Am J Kidney Dis 2013; 61:899–909.
35. Akimoto T, Shiizaki K, Sugase T, Watanabe Y, Yoshizawa H, Otani N, et al. The relationship between the soluble klotho protein and the residual renal function among peritoneal dialysis patients. Clin Exp Nephrol 2012; 16:442–7.
36. Golembiewska E, Safranow K, Kabat-Koperska J, Myslak M, Ciechanowski K. Serum soluble klotho protein level is associated with residual diuresis in incident peritoneal dialysis patients. Acta Biochim Pol 2013; 60:191–4.
37. Mitobe M, Yoshida T, Sugiura H, Shirota S, Tsuchiya K, Nihei H. Oxidative stress decreases klotho expression in a mouse kidney cell line. Nephron Exp Nephrol 2005; 101:e67–74.
38. Saito K, Ishizaka N, Mitani H, Ohno M, Nagai R. Iron chelation and a free radical scavenger suppress angiotensin ii-induced downregulation of klotho, an anti-aging gene, in rat. FEBS Lett 2003; 551:58–62.
39. Shimamura Y, Hamada K, Inoue K, Ogata K, Ishihara M, Kagawa T, et al. Serum levels of soluble secreted alpha-klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis. Clin Exp Nephrol 2012; 16:722–9.
40. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994; 47:1245–51.